Skip to main content

Advertisement

Table 1 Baseline characteristics of the study cohort

From: Trends of loss of peripheral muscle thickness on ultrasonography and its relationship with outcomes among patients with sepsis

Variables Observation (N = 70)
Age (mean ± SD, years) 55.91 ± 14.08
Gender
 Male (%) 45 (64.3%)
APACHE-II score (mean ± SD) 17.17 ± 4.42
SOFA score (mean ± SD, day 1) 5.71 ± 2.05
Height (mean ± SD, cm) 158.45 ± 5.89
Haemoglobin (mean ± SD, gm/dl) 12.29 ± 2.07
Haematocrit (mean ± SD, gm/dl) 39.55 ± 7.32
Leukocyte counts (mean ± SD, per dl) 13,799 ± 4998
Blood Urea [median (interquartile range), mg/dl] 54 (13–191)
Serum creatinine [median (interquartile range), mg/dl] 0.9 (0.3–4.7)
Serum bilirubin [median (interquartile range), mg/dl] 0.6 (0.2–3.7)
Serum albumin (mean ± SD, gm/dl) 3.17 ± 0.49
Serum calcium (mean ± SD, gm/dl) 8.02 ± 0.76
Serum phosphate (mean ± SD, gm/dl) 3.27 ± 1.12
Anterior arm muscle thickness (mean ± SD, mm) 23.13 ± 4.83
Quadriceps muscle thickness (mean ± SD, mm) 31.21 ± 8.56
Source of infection
 Lower respiratory tract 67(95.7%)
 Urinary tract 3(4.3%)
Co-morbidities
 COPD 40(57%)
 Asthma 7(10%)
 Bronchiectasis 7(10%)
 Interstitial lung diseases 2(3%)